Recombinant PIP anticorps (AA 1-146)
Aperçu rapide pour Recombinant PIP anticorps (AA 1-146) (ABIN7868169)
Antigène
Voir toutes PIP AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 1-146
-
Fonction
- GCDFP-15 Antibody / Gross cystic disease fluid protein 15 / Prolactin-Induced Protein
-
Purification
- Protein A/G affinity
-
Immunogène
- A recombinant partial protein sequence (within amino acids 1-146) from the human protein was used as the immunogen for the GCDFP-15 antibody.
-
Isotype
- IgG, kappa
-
-
-
-
Indications d'application
- Optimal dilution of the GCDFP-15 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the GCDFP-15 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- PIP (Prolactin-Induced Protein (PIP))
-
Autre désignation
- GCDFP-15
-
Sujet
- It recognizes a protein of 15 kDa, identified as Gross cystic disease fluid protein 15 (GCDFP-15). It is a major protein component of benign breast gross cysts. It is a known marker of breast cancer, as it is found in approximately 50 % of all breast cancer specimens. GCDFP-15, also known as Prolactin-Induced Protein (PIP), for prolactin inducible protein, is a prolactin and androgen-controlled protein. This antibody is useful in the identification of metastatic breast carcinoma, or fluid analysis.
-
UniProt
- P12273
Antigène
-